1. Impact of different growth hormone levels on gut microbiota and metabolism in short stature.
- Author
-
Li L, Wang Y, Huang Y, Lu Y, Wang W, Chen X, Shan X, Gao H, and Yan Z
- Subjects
- Humans, Child, Male, Female, Case-Control Studies, Metabolome, Body Height, RNA, Ribosomal, 16S genetics, Dwarfism, Pituitary metabolism, Dwarfism, Pituitary drug therapy, Growth Hormone metabolism, Growth Hormone blood, Bacteria metabolism, Gastrointestinal Microbiome, Feces microbiology, Human Growth Hormone metabolism, Growth Disorders microbiology
- Abstract
Background: Growth hormone deficiency(GHD) and idiopathic short stature(ISS) are the primary causes of short stature in children. Animal experiments have revealed a link between growth hormone(GH), gut microbiota and metabolism, however, limited information is available from human trials., Methods: Fecal samples collected from GHD (n = 36), ISS (n = 32) and healthy control (HC) children(n = 16) were subjected to microbiome (16 S rRNA gene sequencing) and metabolome (nuclear magnetic resonance,NMR) analyses., Results: GHD, ISS and HC exhibit distinct differences in beta diversity of gut microbiota.In addition, short stature (GHD and ISS) exhibit higher relative abundance of Prevotellaceae_NK3B31_group at genus level compared to HC, whereas Rodentibacter, Rothia, and Pelomonas showed lower abundance. Additionally,Fusobacterium_mortiferum was identified as the characteristic species of GHD. Moreover, glucose metabolism, pyruvate metabolism and pyrimidine metabolism might play significant roles for distinguishing between GHD and normal GH groups (ISS and HC). Furthermore, a disease prediction model based on differential bacteria and metabolites between GHD and ISS exhibited high diagnostic value., Conclusion: These findings highlight the characteristics of different GH levels on the gut microbiota and metabolism in children, providing novel perspectives for early diagnosis and prognostic treatment of short stature with abnormal GH levels., Impact: The key message of our study is to identify human-relevant gut microbiota and host metabolic patterns that are interfered with growth hormone levels, and to develop biomarker models to identify short stature associated with growth hormone deficiency. We used idiopathic short stature as a control group for growth hormone deficiency, complementing the absence of height as a factor in the existing literature. Our study ultimately hopes to shed new light on the diagnosis and treatment of short stature children associated with growth hormone deficiency., (© 2024. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.)
- Published
- 2024
- Full Text
- View/download PDF